C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: kr1.5B

Carasent ASA
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Carasent ASA
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Total Other Income
kr6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nordhealth AS
OSE:NORDH
Total Other Income
€785k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Codelab Capital AS
OSE:CODE
Total Other Income
kr1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Total Other Income
kr28.1m
CAGR 3-Years
562%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
Not Available
C

See Also

What is Carasent ASA's Total Other Income?
Total Other Income
6.9m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Total Other Income amounts to 6.9m NOK.

What is Carasent ASA's Total Other Income growth rate?
Total Other Income CAGR 1Y
-49%

Over the last year, the Total Other Income growth was -49%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett